X Bioscience PCL (BKK:XBIO)

X Bioscience PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.99	9.19	26.75	16.16	28.01	43.42
Cash & Short-Term Investments	3.99	9.19	26.75	16.16	28.01	43.42
Cash Growth	-36.76%	-65.63%	65.57%	-42.33%	-35.48%	-19.22%
Accounts Receivable	14.79	34.63	0.59	3.71	5.07	3.71
Other Receivables	17.2	15.6	28.56	14.12	18.19	11.04
Receivables	31.99	50.23	29.15	17.83	23.26	14.75
Inventory	12.71	11.87	6.76	13.09	35.12	20.23
Prepaid Expenses	1.82	3.19	1.43	1.54	3.28	2.62
Other Current Assets	46.49	32.69	7.09	6.51	9.8	8.69
Total Current Assets	96.99	107.17	71.19	55.12	99.47	89.71
Property, Plant & Equipment	557.56	596.29	213.87	173.56	294.62	226.12
Goodwill	340.15	335.35	246.18	267.44	516.1	516.1
Other Intangible Assets	310.64	319.23	146.54	150.05	364.85	414.37
Long-Term Deferred Tax Assets	0.11	0.13	-	-	-	-
Other Long-Term Assets	55.26	56.17	61.6	53.92	45.55	34.24
Total Assets	1,361	1,414	739.39	700.09	1,321	1,281
Accounts Payable	158.59	46.65	28.22	29.54	71.01	35.52
Accrued Expenses	-	39.3	38.33	25.24	17.5	10.17
Short-Term Debt	240.06	251.86	293.24	340.34	301.54	66.96
Current Portion of Long-Term Debt	3.05	3.05	3.05	3.21	3.14	1.44
Current Portion of Leases	23.36	22.16	26.64	27.23	36.39	23.25
Current Unearned Revenue	-	6.12	1.68	0.38	0.3	0.83
Other Current Liabilities	-	64.14	35.02	31.17	28.05	21.14
Total Current Liabilities	425.05	433.26	426.2	457.12	457.94	159.31
Long-Term Debt	5.45	5.93	8.29	10.68	13.2	9.47
Long-Term Leases	50.68	71.57	83.81	91.51	114.78	100.36
Long-Term Unearned Revenue	-	-	-	-	-	0.02
Long-Term Deferred Tax Liabilities	63.09	64.88	27.88	29.01	34.65	40.3
Other Long-Term Liabilities	7.06	5.88	7.15	6.94	19.66	16.78
Total Liabilities	557.21	586.93	556.58	597.55	647.19	332.44
Common Stock	2,098	1,944	1,031	813.91	813.91	12,209
Retained Earnings	-1,439	-1,376	-1,116	-968.77	-397.91	-939.72
Comprehensive Income & Other	-163.6	-53.66	268.5	257.4	257.4	-10,321
Total Common Equity	495.37	513.52	182.8	102.54	673.4	948.1
Minority Interest	308.15	313.91	0	0	0	0
Shareholders' Equity	803.52	827.43	182.81	102.54	673.41	948.11
Total Liabilities & Equity	1,361	1,414	739.39	700.09	1,321	1,281
Total Debt	322.6	354.56	415.04	472.98	469.05	201.48
Net Cash (Debt)	-318.61	-345.37	-388.29	-456.82	-441.04	-158.06
Net Cash Per Share	-0.21	-0.27	-0.44	-0.56	-0.54	-0.23
Filing Date Shares Outstanding	2,098	1,944	1,031	813.91	813.91	813.91
Total Common Shares Outstanding	2,098	1,944	1,031	813.91	813.91	813.91
Working Capital	-328.06	-326.09	-355.01	-402	-358.47	-69.6
Book Value Per Share	0.24	0.26	0.18	0.13	0.83	1.16
Tangible Book Value	-155.43	-141.06	-209.92	-314.95	-207.55	17.63
Tangible Book Value Per Share	-0.07	-0.07	-0.20	-0.39	-0.26	0.02
Land	-	126	-	-	-	-
Machinery	-	354.01	70.33	72.44	123.46	101.12
Construction In Progress	-	8.56	16.51	2.3	11.08	3.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.